T2 Biosystems Inc
NASDAQ:TTOO 3:59:22 PM EDT
| Market Cap (Intraday) | 24.81M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.16 |
| 50-Day MA | $0.15 |
| 200-Day MA | $0.38 |
T2 Biosystems Inc Stock, NASDAQ:TTOO
101 Hartwell Avenue, Lexington, Massachusetts 02421
United States of America
Phone: +1.781.761.4646
Number of Employees: 182
Description
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.